1. Allogeneic bone marrow transplantation with related donors other than HLA MLC-matched siblings, and the use of anti-thymocyte globulin, prednisone, and methotrexate for prophylaxis of graft-versus-host disease;Filipovich;Transplantation.,1985
2. A prospective randomized study of acute graft-v-host disease in 107 patients with leukemia: methotrexate/prednisone v. cyclosporine A/prednisone;Forman;Transplant Proc.,1987
3. Cyclosporine plus methylprednisolone versus cyclophosphamide plus methylprednisolone as prophylaxis for graft-versus-host disease: a randomized double-blind study in patients undergoing allogeneic marrow transplantation;Santos;Clin Transplant.,1987
4. Cyclosporine, methotrexate, and prednisone compared with cyclosporine and prednisone for prophylaxis of acute graft-versus-host disease;Chao;N Engl J Med.,1993
5. Combination graft-versus-host disease prophylaxis using immunotoxin (anti-CD5-RTA [Xomazyme-CD5]) plus methotrexate and cyclosporine or prednisone after unrelated donor marrow transplantation;Weisdorf;Bone Marrow Transplant.,1993